Rui Cao Selected Research

heparin receptor

4/2012

Gekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast growth factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rui Cao Research Topics

Disease

39	Neoplasms (Cancer) 04/2022 - 01/2008
11	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 09/2016
10	Inflammation (Inflammations) 07/2017 - 03/2011
6	Breast Neoplasms (Breast Cancer) 08/2021 - 01/2011
6	Keloid 01/2020 - 09/2007
6	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2012
5	Hypoxia (Hypoxemia) 09/2021 - 01/2017
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2019 - 02/2012
4	Obesity 01/2022 - 05/2007
4	Ovarian Neoplasms (Ovarian Cancer) 05/2021 - 05/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 01/2019
4	Asthma (Bronchial Asthma) 01/2020 - 03/2011
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2009
3	Fibrosis (Cirrhosis) 01/2022 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2013
3	Infections 01/2022 - 01/2019
3	Ischemia 01/2022 - 01/2017
3	Insulin Resistance 01/2022 - 10/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2018
3	Carcinoma (Carcinomatosis) 01/2019 - 04/2011
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 03/2011
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 01/2015
3	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 02/2013
2	Ankylosing Spondylitis 05/2022 - 04/2021
2	Reperfusion Injury 01/2022 - 10/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 12/2019
2	Heart Failure 01/2022 - 01/2019
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 01/2016
2	Pain (Aches) 01/2021 - 12/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2020 - 12/2019
2	Carcinogenesis 01/2020 - 10/2016
2	Cognitive Dysfunction 01/2020 - 01/2018
2	Neuroinflammatory Diseases 12/2019 - 08/2012
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2019 - 07/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 03/2019 - 03/2011
2	Lung Neoplasms (Lung Cancer) 01/2019 - 07/2018
2	Brain Hypoxia (Cerebral Hypoxia) 01/2018 - 01/2017
2	Leukemia 01/2017 - 01/2015

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
16	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2010
6	Oxygen (Dioxygen)IBA 05/2022 - 12/2015
6	LigandsIBA 04/2022 - 05/2013
6	Biological ProductsIBA 03/2022 - 09/2008
6	Pharmaceutical PreparationsIBA 01/2022 - 04/2012
6	Peptides (Polypeptides)IBA 12/2020 - 10/2012
6	Messenger RNA (mRNA)IBA 01/2020 - 03/2015
5	LipidsIBA 04/2022 - 10/2013
5	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2016
4	CholesterolIBA 01/2022 - 04/2012
4	Capsules (Microcapsules)IBA 01/2022 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2015
4	Imatinib Mesylate (Gleevec)FDA Link 05/2016 - 02/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 05/2012
3	CalciumIBA 01/2022 - 09/2011
3	Protein Isoforms (Isoforms)IBA 01/2022 - 07/2015
3	Amino Acids FDA Link 01/2022 - 01/2009
3	CateninsIBA 01/2022 - 01/2020
3	ProteomeIBA 01/2022 - 01/2008
3	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 06/2012
3	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2017 - 03/2015
3	Cadherins (E-Cadherin)IBA 01/2016 - 12/2013
3	VimentinIBA 01/2016 - 03/2015
3	SodiumIBA 02/2015 - 10/2012
2	NitrogenIBA 04/2022 - 01/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 01/2015
2	Ion Channels (Ion Channel)IBA 01/2022 - 01/2020
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 01/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 03/2012
2	Insulin (Novolin)FDA Link 01/2022 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2013
2	Long Noncoding RNAIBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	Transfer RNA (tRNA)IBA 01/2022 - 01/2022
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022 - 01/2020
2	Alanine Transaminase (SGPT)IBA 01/2022 - 03/2012
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 10/2013
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020 - 10/2018
2	ErbB Receptors (EGF Receptor)IBA 03/2020 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 03/2020 - 04/2016
2	Immune Checkpoint InhibitorsIBA 01/2020 - 09/2019
2	Amyloid (Amyloid Fibrils)IBA 11/2018 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 11/2018 - 12/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2018 - 10/2016
2	Codon (Codons)IBA 07/2018 - 09/2007
2	Neuroprotective AgentsIBA 01/2018 - 01/2017
2	Fibronectins (Fibronectin)IBA 07/2017 - 05/2016
2	MucinsIBA 01/2017 - 01/2015
2	EnzymesIBA 01/2017 - 09/2012
2	Simvastatin (Zocor)FDA LinkGeneric 10/2016 - 04/2012
2	Capsaicin (Zostrix)FDA Link 10/2016 - 10/2016
2	Sodium Channels (Sodium Channel)IBA 01/2016 - 02/2015

Therapy/Procedure

14	Therapeutics 01/2022 - 03/2011
4	Immunotherapy 09/2021 - 12/2020
4	Drug Therapy (Chemotherapy) 01/2020 - 06/2014
3	Transplantation 01/2022 - 10/2014
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2013 - 06/2011
2	Hematopoietic Stem Cell Transplantation 03/2019 - 01/2017
2	Induction Chemotherapy 01/2017 - 03/2011